PROFESSIONAL EDITION

The largest community of pharma leaders

GVK BIO Announces the Appointment of Axel Schleyer, Ph.D. as Chief Executive Officer, Aragen Bioscience, Inc.

HYDERABAD, India & MORGAN HILL, Calif.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/Antibodydiscovery?src=hash" target="_blank"gt;#Antibodydiscoverylt;/agt;–GVK BIO announces the appointment of Axel Schleyer, Ph.D. as Chief Executive Officer, Aragen Bioscience, Inc. http://www.businesswire.com/news/home/20190508005032/en/GVK-BIO-Announces-Appointment-Axel-Schleyer-Ph.D./?feedref=JjAwJuNHiystnCoBq_hl-WBlLQO14j4QZPTyX5CYOnwC4VjN53jumZRlnzhBoBxGrCOi9QzgjCezTS3Nw_X6kJUrpSBm-Hav1w-UkdSlG3ltkRSnqzf6ourQGu_UA28CzZCGORvG0LE20YOvo49uqw==

Recent Articles